Dr. Ankur Pruthi

Head of Department (HOD)

14 Years of Experience

Nuclear Medicine

MBBS, DNB, Fellowship

Manipal Hospital, Dwarka, Delhi

English

Consultation Fee ₹ 1100

Book an Appointment

About Dr. Ankur Pruthi

Dr. Ankur Pruthi is a well-known Nuclear Medicine Physician proficient in both diagnostic and therapeutic applications of Nuclear Medicine.
With over 14 years of experience, his expertise includes Radionuclide scans and therapy, Nuclear Oncology, Nuclear Cardiology, and Thyroid disorders.
His educational qualifications include MBBS from PGIMS, Rohtak, Haryana, 2007, and a Diploma in Radiation Medicine - BARC, Mumbai, Maharashtra, 2010.
He also completed his DNB (Nuclear Medicine) from the National Board of Education, New Delhi, in 2016.
He was awarded a Fellowship by the Singapore Nuclear Medicine Society” during the Annual conference held in Singapore in August 2017 and a Fellowship of the Asian Nuclear Medicine Board (FANMB) by the Asian Nuclear Medicine Board in Shanghai, China, in May 2019.
He is a certified “Fellow of the European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany, 2015.
With a passion for research and academic pursuits, Dr. Pruthi has numerous international research publications credited to his name.
He is a member of the Society of Nuclear Medicine India (SNMI), the World Association of Radiopharmaceutical Therapy (WARMTH), and the European Association of Nuclear Medicine (EANM).

Book Your Appointment With Dr. Ankur Pruthi

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS - PGIMS, Rohtak, Haryana, 2007
Diploma in Radiation Medicine - BARC, Mumbai, Maharashtra, 2010
The postgraduate certificate course in “Paediatric Nuclear Medicine” was conducted by FMRI, Gurgaon, and GOSH, London, in 2014
Certified “Fellow of the European Board of Nuclear Medicine (FEBNM)” in Hamburg, Germany, 2015
DNB (Nuclear Medicine) - National Board of Education, New Delhi, 2016
Fellowship by Singapore Nuclear Medicine Society, 2017
Fellow of the Asian Nuclear Medicine Board (FANMB), Shanghai, China, 2019

Past Experience

Clinical Assistant at Rajiv Gandhi Cancer Institute - 2013 - 2014
Nuclear Medicine Physician at Mahajan Imaging, Sir Ganga Ram Hospital - 2014 - 2018
Head, Nuclear Medicine at Manipal Hospitals, Dwarka - 2018 - 2018

Awards

“Best oral Presentation (clinical)” at the SNMI annual conference held at PGIMER, Chandigarh, India in November 2010.
Awarded “International Travel Grant” by the Department of Science & Technology, Government of India in 2010.
“Best Poster presentation” in Indian Cancer Congress 2013 held in New Delhi.
Certificate, Paediatric Nuclear Medicine (FMRI & GOSH, London).

Paper Published

Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy at the Society of Nuclear Medicine India annual conference (SNMICON), Chandigarh, 2010.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at 4th International Conference on Radiopharmaceutical Therapy (ICRT) held at Ho Chi Minh City, Vietnam in 2011.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at BREASTCON held at New Delhi in 2013.
Role of 18F-Fluoro-Deoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging (18F-FDG PET/CT) for Preoperative Axillary Staging in Primary Breast Cancer: A Prospective Analysis” at Indian Cancer Congress held at New Delhi in 2013.
Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumors of unknown origin and its impact on clinical decision making: experience from a tertiary care center in India at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuroendocrine tumors (NETs) at the European Association of Nuclear Medicine annual conference (EANM) in Hamburg, Germany, in October 2015.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic esophageal and gastro-esophageal junction carcinoma at European Association of Nuclear Medicine annual conference (EANM) at Hamburg, Germany in October 2015.
Role of F-18 FDG PET CT in Predicting Pathologic Response to Neoadjuvant Chemo-radiotherapy and Survival in Patients of Non-metastatic Esophageal and gastro-esophageal Junction Carcinoma at International Conference of Radiopharmaceutical Therapy (ICRT) held at Vienna, Austria in 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Society of Nuclear Medicine India Conference (SNMICON) held at Ahmedabad in December 2016.
Evaluation Of Role Of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Role of F-18 FDG PET CT in predicting pathologic response to neoadjuvant chemo-radiotherapy and survival in patients of non-metastatic esophageal and gastro-esophageal junction carcinoma at European Association of Nuclear Medicine annual conference at Singapore Nuclear Medicine Update (SNMU) in August 2017.
To retrospectively evaluate the utility of Ga-68 DOTANOC PET CT scan in analyzing rare or unusual neuroendocrine tumors (NETs) at Singapore Nuclear Medicine Update (SNMU) in August 2017.
Evaluation Of Role of F-18 FDG Cardiac Pet And Tc-99m Sestamibi Myocardial Perfusion Imaging In Assessing The Therapeutic Benefit In Patients With Coronary Artery Disease And Left Ventricular Systolic Dysfunction at Asia-Oceania Conference of Nuclear Medicine and Biology (AOCNMB) held at Shanghai in May 2019.
Pruthi A, Asopa R, Rajan M, Basu S. Quantitative analysis of SPECT imaging parameters in patients with resting perfusion defects on myocardial perfusion scintigraphy. Indian J Nucl Med. 2010; 25:135-138.
Pruthi A, Basu S, Ramani SK, Arya S. Bilateral symmetrical adrenal hypermetabolism on FDG PET in paraneoplastic Cushing syndrome in breast carcinoma: correlation with contrast-enhanced computed tomography. Clin Nucl Med. 2010; 35: 960-961.
Pruthi A, Chauhan VV, Rao SA, Choudhury PS. Incidentally detected arterial thrombosis in (99m)Tc-methylene diphosphonate skeletal scintigraphy: an atypical observation. Clin Nucl Med. 2014; 39:190-192.
Gupta M, Choudhary P, Jain A, Pruthi A. Solitary spinal epidural metastasis from lung carcinoma. Indian J Nucl Med. 2014; 29:38-39
Doval DC, Azam S, Mehta A, Pruthi A, Batra U, Choudhury KD, Kumar K. A report of sarcomatoid carcinoma of the gallbladder treated with palliative docetaxel and gemcitabine chemotherapy. J Gastrointest Cancer. 2014 Dec; 45 Suppl 1:270-4.
Pruthi A, Choudhury PS, Gupta M, Taywade S. Does the intensity of diffuse thyroid gland uptake on F-18 fluorodeoxyglucose positron emission tomography/computed tomography scan predict the severity of hypothyroidism? Correlation between maximal standardized uptake value and serum thyroid-stimulating hormone levels. Indian J Nucl Med. 2015 Jan-Mar;30(1):16-20.
Sharma S, Pruthi A. The diagnostic significance of breast incidentalomas detected on whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Asian J Oncol 2015; 1: 92-96.
Pruthi A, Pankaj P, Verma R, Jain A, Belho ES, Mahajan H. Ga-68 DOTANOC PET/CT imaging in the detection of the primary site in patients with metastatic neuroendocrine tumors of unknown origin and its impact on clinical decision making: experience from a tertiary care center in India. J Gastrointest Oncol. 2016 Jun;7(3):449-61.
Gupta N, Pruthi A, Kumar S, Verma R, Belho ES. Fibrodysplasia Ossificans Progressiva - A Rare Genetic Disorder and the Role of Technetium-99m Methylene Diphosphonate Bone Scan. Indian J Nucl Med. 2019;34(3):209–212.